RENASANT CORP
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
RNST$40.19+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (Unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating activities | ||
| Net income | $88,228 | $41,518 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Provision for credit losses | 8,080 | 4,750 |
| Depreciation, amortization and accretion | 273 | 8,360 |
| Deferred income tax expense | 6,827 | 954 |
| Funding of mortgage loans held for sale | (342,536) | (303,158) |
| Proceeds from sales of mortgage loans held for sale | 380,395 | 328,897 |
| Gains on sales of mortgage loans held for sale | (5,305) | (4,500) |
| Losses (gains) on sales of premises and equipment | 10 | (271) |
| Stock-based compensation | 5,474 | 3,780 |
| Income from bank-owned life insurance | (3,689) | (2,929) |
| Net change in operating leases | 1,496 | 1,335 |
| (Decrease) in other assets | (25,228) | (8,613) |
| Decrease in other liabilities | (13,970) | (20,025) |
| Net cash provided by operating activities | 100,055 | 50,098 |
| Investing activities | ||
| Purchases of securities available for sale | (378,991) | (175,815) |
| Proceeds from call/maturities of securities available for sale | 116,604 | 30,958 |
| Proceeds from call/maturities of securities held to maturity | 24,859 | 25,831 |
| Net decrease (increase) in loans | 79,767 | (171,186) |
| Purchases of premises and equipment | (6,327) | (4,817) |
| Proceeds from sales of premises and equipment | 12 | 1,267 |
| Proceeds from surrender of bank-owned life insurance | — | 56,255 |
| Purchases of FHLB stock | 16,015 | — |
| Proceeds from redemption of FHLB stock | (1,175) | (222) |
| Purchases of FRB stock | (91,127) | — |
| Proceeds from sales of other assets | 6,151 | 746 |
| Other, net | 1,356 | 982 |
| Net cash used in investing activities | (232,856) | (236,001) |
| Financing activities | ||
| Net increase in deposits | 626,414 | 199,483 |
| Net decrease in short-term borrowings | (249,911) | (3) |
| Cash paid for dividends | (21,634) | (14,270) |
| Repurchase of shares in connection with stock repurchase program | (75,806) | — |
| Net cash provided by financing activities | 279,063 | 185,210 |
| Net increase (decrease) in cash and cash equivalents | 146,262 | (693) |
| Cash and cash equivalents at beginning of period | 1,070,718 | 1,092,032 |
| Cash and cash equivalents at end of period | $1,216,980 | $1,091,339 |
| Supplemental disclosures | ||
| Cash paid for interest | $113,261 | $85,839 |
| Cash paid for income taxes | $2,761 | $— |
| Noncash transactions: | ||
| Transfers of loans to other real estate owned | $4,955 | $1,296 |
| Recognition of operating right-of-use assets and liabilities | $2,053 | $565 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.